| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/14760584.5.2.211 |
| P698 | PubMed publication ID | 16608421 |
| P2093 | author name string | Matthias Klammer | |
| Patrick H Roddie | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Dendritic cells and the control of immunity | Q27860918 | ||
| Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein | Q28204172 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| The dendritic cell system and its role in immunogenicity | Q29619870 | ||
| Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application | Q33536357 | ||
| The role of dendritic cells in the induction and regulation of immunity to microbial infection. | Q33711401 | ||
| Dendritic cell regulation of TH1-TH2 development | Q34023428 | ||
| Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia | Q34412762 | ||
| Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia | Q34808353 | ||
| Induction of antigen-specific T cell anergy: An early event in the course of tumor progression | Q35798927 | ||
| Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming | Q36371607 | ||
| Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes | Q36399533 | ||
| Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression | Q37535549 | ||
| Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. | Q39741064 | ||
| NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. | Q40493871 | ||
| CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. | Q40614121 | ||
| Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells. | Q40646153 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial | Q43886638 | ||
| CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia | Q44117644 | ||
| Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation | Q44993179 | ||
| Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
| Human renal-cell carcinoma tissue contains dendritic cells | Q71733527 | ||
| Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen | Q71931319 | ||
| Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells | Q73475202 | ||
| Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells | Q73607376 | ||
| The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses | Q73822494 | ||
| Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia | Q74268543 | ||
| Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
| Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 | Q77959433 | ||
| Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease | Q77966217 | ||
| Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin | Q77995830 | ||
| Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes | Q80398227 | ||
| P433 | issue | 2 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 211-222 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Expert Review of Vaccines | Q15756339 |
| P1476 | title | Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia | |
| P478 | volume | 5 |
| Q57537615 | Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules | cites work | P2860 |
Search more.